Alexion Pharmaceuticals (ALXN) reported third quarter EPS of $0.37 Thursday morning, which came in above the consensus estimate of $0.21. The company also increased its full year EPS forecast to between $1.15 and $1.18, from prior guidance of $1.01 to $1.06. Alexion Pharmaceuticals gapped up sharply Thursday and climbed in early trade. Shares rose further late in the afternoon and closed higher by $3.68 at $47.81 on the highest volume in nearly 4 months. The stock broke out of a 2-month range and set a new high for the year.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.